Cofepris authorized the emergency use of the Indian vaccine Covaxin, so Mexico now has six approved vaccines against Covid-19.
This was confirmed this Tuesday by the Chancellor Marcelo Ebrard on his Twitter account, where he detailed that the country now has AstraZeneca, Cansino, Covaxin, Pfizer, Sinovac and Sputnik V.
With the emergency authorization to COVAXIN our country has as of today six approved vaccines against covid-19: AstraZeneca, Cansino, Covaxine, Pfizer, Sinovac and Sputnik V.
– Marcelo Ebrard C. (@m_ebrard) April 7, 2021
Given this, the undersecretary stressed that it was “very timely” the decision of the Cofepris to authorize the emergency use of the vaccine manufactured in India.
Read also: Mexico exceeds 205 thousand deaths from Covid-19
Covaxin is 81% effective
The vaccine developed by the Indian laboratory Bharat Biotech and the Indian Council for Medical Research (ICMR) offers efficacy against coronavirus in 81% of cases, based on interim results revealed by Bharat Biotech.
The drug against Covid-19 “demonstrated a provisional vaccine efficacy of 81% in its phase 3 clinical trial. The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with the Indian Council for Medical Research, “the lab said in a statement.
Covaxin “demonstrated a trend of high clinical efficacy against Covid-19, but also significant immunogenicity against rapidly emerging variants,” said Dr. Krishna Ella, President and CEO of Bharat Biotech.
Continue reading: Indian Covid Vaccine, Covaxin, 81% Efficient, According to Manufacturer
Why didn’t Brazil approve it?
A week ago, on March 30, Brazil refused to grant a necessary certificate for the use of the Indian anticovid vaccine Covaxin, after analyzing the risks that its application would represent in this South American country.
The National Health Surveillance Agency (Anvisa, regulator) said in a statement that it had rejected the so-called “good practice certificate” presented by the company responsible for the vaccine, Bharat Biotech.
This authorization is one of the previous steps so that vaccines such as Covaxin can be used in this country, the second in the whole world in terms of the accumulated level of infected by the new coronavirus and deceased by Covid-19, after the United States.
The decision on the certificate required by Covaxin was taken after Anvisa representatives carried out an inspection at the Indian company’s factory between March 1-5.
Paraguay also authorizes its use
Paraguay, at the tail end of the region in immunization against Covid, will be able to use the 100,000 vaccines donated by India that it kept in storage after the authorization this Tuesday from the Mexican health regulatory body for the emergency use of Covaxin.
The announcement of the Federal Commission for the Protection Against Sanitary Risks of Mexico (Cofepris) was published on his twitter account by the Paraguayan president, Mario Abdo Benítez, whose government is questioned by the slowness of the vaccination campaign, which at the moment only it affects white personnel.
For its part, from the Ministry of Health announced a press conference this Wednesday to inform about the procedure to be followed from now on.
** With information from EFE
rcr/cev
.
